Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-005217

Chairman and CEO gave up 25,710 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KAZIMI A J Chairman and CEO 2024-03-23 Shares withheld for taxes −25,710 $1.81 $46,535 5,695,557 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
KAZIMI A J Chairman and CEO 2024-03-25 Grant or award · Options (right to buy) +100,000 368,000 D: show line 2 in the form
Loading xslF345X05/marketforms-65385.xml…